Clinical Trial Update: Trial of Pre-operative Neratinib and Endocrine Therapy With Trastuzumab in ER-Positive, HER-2 Positive Breast Cancers [Phase 2]

View source ↗

Summary

Phase 2 clinical trial evaluating pre-operative Neratinib and Trastuzumab with endocrine therapy for ER-positive, HER2-positive breast cancers. The study is cur…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer
• Estrogen Receptor-positive Breast Cancer
• Progesterone Receptor-positive Breast Cancer

Drugs mentioned

• Trastuzumab (trastuzumab)
• neratinib (neratinib)

Snippet

Sponsor: Ruth O'Regan | Conditions: Breast Cancer, HER2-positive Breast Cancer | Phase 2 | Status: RECRUITING